痘苗病毒载体：生产重组疫苗的新策略。
Vaccinia virus vectors: new strategies for producing recombinant vaccines.
作者信息
Hruby D E
机构信息
Department of Microbiology, Oregon State University, Corvallis 97331-3804.
出版信息
Clin Microbiol Rev. 1990 Apr;3(2):153-70. doi: 10.1128/CMR.3.2.153.
Abstract
The development and continued refinement of techniques for the efficient insertion and expression of heterologous DNA sequences from within the genomic context of infectious vaccinia virus recombinants are among the most promising current approaches towards effective immunoprophylaxis against a variety of protozoan, viral, and bacterial human pathogens. Because of its medical relevance, this area is the subject of intense research interest and has evolved rapidly during the past several years. This review (i) provides an updated overview of the technology that exists for assembling recombinant vaccinia virus strains, (ii) discusses the advantages and disadvantages of these approaches, (iii) outlines the areas of outgoing research directed towards overcoming the limitations of current techniques, and (iv) provides some insight (i.e., speculation) about probable future refinements in the use of vaccinia virus as a vector.
摘要
在感染性痘苗病毒重组体的基因组背景下高效插入和表达异源DNA序列的技术的发展及持续完善，是目前针对多种原生动物、病毒和细菌性人类病原体进行有效免疫预防的最具前景的方法之一。由于其医学相关性，该领域是研究的热点，在过去几年中发展迅速。本综述：（i）提供了用于组装重组痘苗病毒株的现有技术的最新概述；（ii）讨论了这些方法的优缺点；（iii）概述了旨在克服现有技术局限性的未来研究领域；（iv）对痘苗病毒作为载体的可能未来改进提供了一些见解（即推测）。
相似文献
1
Vaccinia virus vectors: new strategies for producing recombinant vaccines.痘苗病毒载体：生产重组疫苗的新策略。
Clin Microbiol Rev. 1990 Apr;3(2):153-70. doi: 10.1128/CMR.3.2.153.
2
Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.痘苗病毒载体作为候选疫苗：用于抗原递送的改良安卡拉痘苗病毒的研发。
Curr Drug Targets Infect Disord. 2003 Sep;3(3):263-71. doi: 10.2174/1568005033481123.
3
Protective efficacy of a recombinant vaccinia virus in vaccinia-immune mice.重组痘苗病毒在痘苗免疫小鼠中的保护效力
Immunol Cell Biol. 1989 Oct;67 ( Pt 5):339-41. doi: 10.1038/icb.1989.49.
4
Roles of vaccinia virus in the development of new vaccines.痘苗病毒在新型疫苗研发中的作用。
Vaccine. 1988 Apr;6(2):161-3. doi: 10.1016/s0264-410x(88)80021-5.
5
Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2.表达人白细胞介素-2的痘苗病毒重组体在灵长类动物中的减毒作用和免疫原性。
Vaccine. 1990 Feb;8(1):17-21. doi: 10.1016/0264-410x(90)90171-h.
6
Present and future applications of vaccinia virus as a vector.痘苗病毒作为载体的当前及未来应用
Vet Parasitol. 1988 Sep;29(2-3):281-92. doi: 10.1016/0304-4017(88)90129-x.
7
Recombinant live virus vaccines.重组活病毒疫苗
Immunol Lett. 1987 Dec;16(3-4):243-8. doi: 10.1016/0165-2478(87)90153-2.
8
[Modified vaccinia virus ankara (MVA)--development as recombinant vaccine and prospects for use in veterinary medicine].[安卡拉改良痘苗病毒（MVA）——作为重组疫苗的研发及在兽医学中的应用前景]
Berl Munch Tierarztl Wochenschr. 2015 Nov-Dec;128(11-12):464-72.
9
Uses of vaccinia virus in vaccine delivery.痘苗病毒在疫苗递送中的应用。
Curr Opin Biotechnol. 1994 Oct;5(5):501-4. doi: 10.1016/0958-1669(94)90064-7.
10
Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.痘苗病毒及表达异源基因的病毒重组株的抗原特性。
Acta Virol. 1988 Sep;32(5):409-16.
引用本文的文献
1
Efficacy and immunogenicity of rKVAC85B in a BCG prime-boost regimen against H37Rv and HN878 Mycobacterium tuberculosis strains.rKVAC85B在卡介苗初免-加强免疫方案中对H37Rv和HN878结核分枝杆菌菌株的疗效和免疫原性。
PLoS One. 2025 May 14;20(5):e0322147. doi: 10.1371/journal.pone.0322147. eCollection 2025.
2
Assessing the generation of tissue resident memory T cells by vaccines.评估疫苗产生组织驻留记忆 T 细胞的能力。
Nat Rev Immunol. 2023 Oct;23(10):655-665. doi: 10.1038/s41577-023-00853-1. Epub 2023 Mar 31.
3
Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge.用改良安卡拉痘苗病毒载体进行表皮免疫可产生针对呼吸道病毒攻击的更强的T细胞免疫力。
NPJ Vaccines. 2021 Jan 4;6(1):1. doi: 10.1038/s41541-020-00265-5.
4
Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma.病毒载体作为治疗胶质母细胞瘤的基因治疗剂
Cancers (Basel). 2020 Dec 11;12(12):3724. doi: 10.3390/cancers12123724.
5
Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency.痘苗病毒重组：deVV5，一种具有增强溶瘤效力的新型嵌合痘病毒。
Cancers (Basel). 2018 Jul 10;10(7):231. doi: 10.3390/cancers10070231.
6
Establishing elements of a synthetic biology platform for Vaccinia virus production: BioBrick™ design, serum-free virus production and microcarrier-based cultivation of CV-1 cells.建立用于痘苗病毒生产的合成生物学平台的要素：BioBrick™ 设计、无血清病毒生产以及基于微载体的 CV-1 细胞培养。
Heliyon. 2017 Feb 4;3(2):e00238. doi: 10.1016/j.heliyon.2017.e00238. eCollection 2017 Feb.
7
Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors.报告基因在痘苗病毒衍生载体构建中的应用
Viruses. 2016 May 21;8(5):134. doi: 10.3390/v8050134.
8
Somatostatin receptor based imaging and radionuclide therapy.基于生长抑素受体的成像与放射性核素治疗。
Biomed Res Int. 2015;2015:917968. doi: 10.1155/2015/917968. Epub 2015 Mar 24.
9
Expression of herpes simplex virus type 1 DNA polymerase by recombinant vaccinia virus.重组痘苗病毒对单纯疱疹病毒1型DNA聚合酶的表达
Virus Genes. 2009 Apr;38(2):232-42. doi: 10.1007/s11262-009-0330-9. Epub 2009 Feb 5.
10
Vaccinia virus entry, exit, and interaction with differentiated human airway epithelia.痘苗病毒进入、离开及与分化的人气道上皮细胞的相互作用。
J Virol. 2007 Sep;81(18):9891-9. doi: 10.1128/JVI.00601-07. Epub 2007 Jun 20.
本文引用的文献
1
Current knowledge of type-specific M antigens of group A streptococci.A组链球菌特定类型M抗原的现有知识。
J Immunol. 1962 Sep;89:307-13.
2
Control of expression of the vaccinia virus thymidine kinase gene.牛痘病毒胸苷激酶基因表达的调控
J Virol. 1981 Nov;40(2):456-64. doi: 10.1128/JVI.40.2.456-464.1981.
3
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene.痘苗病毒早期基因多个起始和终止位点附近的独特核苷酸序列。
Cell. 1981 Sep;25(3):805-13. doi: 10.1016/0092-8674(81)90188-4.
4
Biology of poxviruses.痘病毒生物学
Virol Monogr. 1981;18:1-109. doi: 10.1007/978-3-7091-8625-1.
5
Molecular genetics of vaccinia virus: demonstration of marker rescue.痘苗病毒的分子遗传学：标记拯救的证明
Proc Natl Acad Sci U S A. 1982 Mar;79(5):1593-6. doi: 10.1073/pnas.79.5.1593.
6
Cellular differences in the molecular mechanisms of vaccinia virus host range restriction.痘苗病毒宿主范围限制分子机制中的细胞差异
J Gen Virol. 1980 Apr;47(2):485-8. doi: 10.1099/0022-1317-47-2-485.
7
Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA.使用M13衍生载体的寡核苷酸定向诱变：在任何DNA片段中产生点突变的高效通用方法。
Nucleic Acids Res. 1982 Oct 25;10(20):6487-500. doi: 10.1093/nar/10.20.6487.
8
Mapping of the vaccinia virus DNA polymerase gene by marker rescue and cell-free translation of selected RNA.通过标记拯救和所选RNA的无细胞翻译对痘苗病毒DNA聚合酶基因进行定位。
J Virol. 1984 Jan;49(1):72-7. doi: 10.1128/JVI.49.1.72-77.1984.
9
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters.表达流感血凝素基因并诱导仓鼠对流感病毒感染产生抗性的传染性痘苗病毒重组体的构建与鉴定。
Proc Natl Acad Sci U S A. 1983 Dec;80(23):7155-9. doi: 10.1073/pnas.80.23.7155.
10
Isolation, characterization, and physical mapping of temperature-sensitive mutants of vaccinia virus.痘苗病毒温度敏感突变体的分离、特性鉴定及物理图谱绘制
Virology. 1983 Jul 30;128(2):429-43. doi: 10.1016/0042-6822(83)90268-4.
Zotero 插件